Weight gain around menopause is real, but it is mostly about where fat goes, not a switch that flips on. Falling estrogen shifts fat toward the abdomen, while ordinary aging accounts for much of the total gain. Hormone therapy does not cause it, and it is not a weight-loss treatment.
Key takeaways
- The menopause transition redistributes fat toward the belly (visceral fat), driven by declining estrogen. Visceral fat can rise from roughly 5 to 8 percent of body fat before menopause to 15 to 20 percent after.
- Most of the total weight gain at midlife is tied to aging, not menopause itself. Menopause changes the shape more than the scale.
- HRT does not cause weight gain (pooled trials find no effect on body weight), and it is not a weight-loss drug. Some evidence suggests it may blunt the shift of fat to the abdomen.
- What actually helps: preserving muscle through resistance training and adequate protein, plus sleep and diet fundamentals.
- For some women, a GLP-1 medication such as semaglutide is an option. The strong trial results are for the FDA-approved branded form; compounded semaglutide is not FDA-approved.
- None of this is one-size-fits-all. A clinician should weigh your history before prescribing hormone therapy or a GLP-1.
"Why am I gaining weight, and why is it all in my middle?" is one of the most common questions in perimenopause, and it deserves an honest answer instead of a supplement pitch. The short version: menopause is real and it does change your body, but not the way most marketing implies. This page separates what menopause actually does to your weight from what aging does, what hormone therapy can and cannot do about it, and what the evidence says actually helps. It connects to the biest cream overview and progesterone with estrogen on the hormone side.
Why do you gain weight during menopause?
Two things happen at once, and pulling them apart matters.
First, aging. Independent of menopause, metabolism and muscle mass decline with age, and that accounts for much of the total weight people put on in their 40s and 50s. This part is not unique to women or to menopause.
Second, estrogen decline, which is unique to the menopause transition and changes where fat sits. As estrogen falls, fat redistributes from the hips and thighs toward the abdomen, including deeper "visceral" fat around the organs. Studies that follow women through the transition find visceral fat climbing from roughly 5 to 8 percent of total body fat before menopause to 15 to 20 percent after, with the rise beginning a few years before the final period as estradiol drops. That is the "menopause belly" people describe: the scale may move modestly, but the middle changes more.
This distinction matters because visceral fat is not just cosmetic. It is metabolically active and linked to higher risk of heart disease and insulin resistance, which is part of why midlife weight is worth taking seriously.
Does HRT cause weight gain?
No. This is one of the most common fears about starting hormone therapy, and the evidence does not support it. A Cochrane review pooling randomized trials found no significant difference in weight between women on hormone therapy and women not taking it. HRT is not the reason the scale moves at menopause.
If anything, the fat-distribution picture leans the other way. Several studies, including the OsteoLaus cohort, associate hormone therapy with less visceral fat and a blunting of the abdominal shift that menopause otherwise drives. That evidence is mixed rather than a slam dunk, so the honest summary is: HRT does not make you gain weight, and it may modestly soften the fat-redistribution part.
Does HRT help you lose weight?
The honest answer matters here too: hormone therapy is not a weight-loss treatment. It treats menopause symptoms (hot flashes, night sweats, sleep disruption, and others), and relieving those can indirectly make weight easier to manage, because better sleep and fewer symptoms make it easier to move and eat well. But HRT is not prescribed to make you lose weight, and you should be skeptical of anyone selling it that way. If weight is your main goal, hormone therapy is not the tool for the job.
What actually helps menopause weight gain
The interventions with the best evidence are not exciting, but they work, and they target the real problem (muscle loss and fat redistribution):
- Resistance training. Strength training is the single most underused lever here. It preserves and builds muscle, and muscle is metabolically active tissue, so keeping it protects your resting metabolism as you age. Randomized trials in postmenopausal women show resistance training improves lean mass and strength.
- Protein. Estrogen decline accelerates muscle loss, which raises protein needs above the old standard. Reviews suggest roughly 1.0 to 1.2 grams per kilogram of body weight for maintenance, and more during active weight loss or training. Protein also increases fullness, which helps with intake.
- Sleep and the basics. Menopause often wrecks sleep, and poor sleep worsens appetite regulation and weight. This is one place where treating menopause symptoms, including with HRT, can indirectly help.
Notice that "eat less, do more cardio" is not the headline. At midlife, protecting muscle is the goal, because losing muscle is what quietly lowers your metabolism.
Where GLP-1 medications fit
For some women, lifestyle alone is not enough, and a medication is appropriate. GLP-1 medications, the class that includes semaglutide, have changed what is possible here. In the large STEP 1 trial, semaglutide produced an average of about 15 percent body-weight loss over roughly a year, compared with about 2 to 3 percent on placebo.
Two honest caveats:
- Those results are for the FDA-approved, branded semaglutide studied in the trials. Compounded semaglutide (made for an individual patient by a compounding pharmacy) is not FDA-approved, and the trial numbers should not be assumed to transfer exactly to a compounded product.
- GLP-1 medications are real medicine with real side effects (most commonly nausea and other gastrointestinal effects, which is why the dose is raised slowly), and they are not appropriate for everyone. They carry specific contraindications, which is why a clinician reviews your history before prescribing.
GLP-1s are also not a shortcut around the muscle-preservation work above. They work best alongside protein and resistance training, not instead of them.
How Therisse handles this
Therisse runs two separate programs, because menopause weight and menopause symptoms are different problems:
- Hormone therapy (biest cream, progesterone, or both) is for menopause symptoms, not weight. For the hormone details, start with the biest cream overview.
- Weight management is a separate program built around compounded semaglutide (with glycine and B12), started at a low dose and titrated up over time. It is dispensed by a licensed 503A compounding pharmacy after a board-certified physician reviews your intake and history.
In plain terms on FDA status: the compounded semaglutide Therisse dispenses is not FDA-approved, the same as the compounded hormone products. Compounded medications are made for an individual patient and are not reviewed as standardized products.
Prescription products require an online consultation with a licensed provider. If a physician does not approve you, your initial consult fee and any medication charge are refunded in full. You can start a visit here.
Compounded products are not FDA-approved. This page is educational and is not medical advice. Hormone therapy carries risks including blood clots, stroke, and breast cancer. GLP-1 medications carry their own risks and contraindications. Talk to a licensed clinician about your individual history before starting either.
Frequently asked questions
Why do you gain belly fat during menopause? Falling estrogen shifts where the body stores fat, from the hips and thighs toward the abdomen, including deeper visceral fat. Studies find visceral fat rising from about 5 to 8 percent of body fat before menopause to 15 to 20 percent after. Aging adds to the total.
Does HRT cause weight gain? No. A Cochrane review of randomized trials found no significant difference in weight between women using hormone therapy and those not. Some evidence suggests HRT may reduce the abdominal fat shift, but it is not a weight-loss treatment.
Does HRT help you lose weight? Not directly. Hormone therapy treats menopause symptoms, and relieving symptoms like poor sleep can make weight easier to manage. But HRT is not a weight-loss drug and is not prescribed for that purpose.
What is the best way to lose menopause weight? The strongest evidence is for preserving muscle: resistance training plus adequate protein (about 1.0 to 1.2 grams per kilogram of body weight, more during active weight loss), along with sleep and diet fundamentals. For some women, a GLP-1 medication is an appropriate addition under medical supervision.
Does semaglutide work for menopause weight gain? Semaglutide produced about 15 percent body-weight loss in the STEP 1 trial of the FDA-approved branded form. Compounded semaglutide is not FDA-approved, and it is not right for everyone. A clinician should review your history first.
Sources
- Adverse changes in body composition during the menopausal transition and relation to cardiovascular risk: a contemporary review. https://pmc.ncbi.nlm.nih.gov/articles/PMC9258798/
- Increased visceral fat and decreased energy expenditure during the menopausal transition. https://pmc.ncbi.nlm.nih.gov/articles/PMC2748330/
- Davis SR, et al. Understanding weight gain at menopause. Climacteric. 2012. https://pubmed.ncbi.nlm.nih.gov/22978257/
- Cochrane. Hormone replacement therapy has no effect on body weight and cannot prevent weight gain at menopause. https://www.cochrane.org/evidence/CD001018_hormone-replacement-therapy-has-no-effect-body-weight-and-cannot-prevent-weight-gain-menopause
- Menopausal hormone therapy is associated with reduced total and visceral adiposity: the OsteoLaus cohort. J Clin Endocrinol Metab. 2018. https://academic.oup.com/jcem/article/103/5/1948/4953992
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Resistance training alters body composition in middle-aged women depending on menopause. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559623/